loading
전일 마감가:
$1.38
열려 있는:
$1.4
하루 거래량:
22,689
Relative Volume:
0.01
시가총액:
$19.58M
수익:
-
순이익/손실:
$-8.83M
주가수익비율:
-1.7961
EPS:
-0.7906
순현금흐름:
$-8.61M
1주 성능:
+1.44%
1개월 성능:
-6.00%
6개월 성능:
+39.60%
1년 성능:
-4.41%
1일 변동 폭
Value
$1.38
$1.42
1주일 범위
Value
$1.28
$1.4798
52주 변동 폭
Value
$0.8588
$2.67

Cocrystal Pharma Inc Stock (COCP) Company Profile

Name
명칭
Cocrystal Pharma Inc
Name
전화
(786) 459-1831
Name
주소
19805 N. CREEK PARKWAY, BOTHELL, WA
Name
직원
10
Name
트위터
@cocrystalpharma
Name
다음 수익 날짜
2026-05-21
Name
최신 SEC 제출 서류
Name
COCP's Discussions on Twitter

Compare COCP vs VRTX, REGN, ARGX, ALNY, ONC

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
COCP icon
COCP
Cocrystal Pharma Inc
1.42 19.02M 0 -8.83M -8.61M -0.7906
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
428.58 107.87B 12.32B 4.34B 3.19B 16.86
REGN icon
REGN
Regeneron Pharmaceuticals Inc
719.58 73.63B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
811.32 49.42B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
304.35 40.20B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
315.54 33.06B 5.36B 287.73M 924.18M 2.5229

Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2020-07-08 개시 H.C. Wainwright Buy

Cocrystal Pharma Inc 주식(COCP)의 최신 뉴스

pulisher
May 04, 2026

[EFFECT] Cocrystal Pharma, Inc. SEC Filing - Stock Titan

May 04, 2026
pulisher
Apr 30, 2026

Cocrystal Showcases Norovirus Candidate CDI-988 at ICAR 2026 - TipRanks

Apr 30, 2026
pulisher
Apr 30, 2026

Cocrystal Pharma (COCP) advances Fast Track CDI-988 in Phase 1b norovirus challenge study - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

No approved norovirus drugs; Cocrystal tests oral CDI-988 - Stock Titan

Apr 30, 2026
pulisher
Apr 28, 2026

COCP stock soars 75% — what is the link to Cocrystal’s norovirus treatment? - MSN

Apr 28, 2026
pulisher
Apr 23, 2026

Cocrystal Pharma Incfiles to offer up to $150 million in securitiesSEC filing - marketscreener.com

Apr 23, 2026
pulisher
Apr 23, 2026

Cocrystal Pharma (NASDAQ: COCP) files $150M shelf to offer stock and warrants - Stock Titan

Apr 23, 2026
pulisher
Apr 22, 2026

COCP: Q4 2025 Earnings: Cocrystal Pharma Inc. posts 4.8% EPS beat with no Q4 revenueTop Analyst Buy Signals - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 22, 2026
pulisher
Apr 22, 2026

Cocrystal (COCP) Stock: Why Efficiency Gains (Momentum Building) 2026-04-22RSI Oversold Stocks - Xã Vĩnh Công

Apr 22, 2026
pulisher
Apr 17, 2026

Why Cocrystal Pharma Shares Are Cooling Off Monday? - MSN

Apr 17, 2026
pulisher
Apr 16, 2026

Form 8-KCurrent report - ADVFN

Apr 16, 2026
pulisher
Apr 15, 2026

Cocrystal Pharma (COCP) price target increased by 33.33% to 8.16 - MSN

Apr 15, 2026
pulisher
Apr 13, 2026

Smart Money: Can Cocrystal Pharma Inc deliver consistent EPS growth2026 Technical Patterns & Daily Growth Stock Tips - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 10, 2026

Investor Mood: Is Cocrystal Pharma Inc benefiting from innovation trendsQuarterly Risk Review & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 10, 2026

What events could move Cocrystal (COCP) Stock next | Price at $1.29, Down 9.79%Crowd Trend Signals - Newser

Apr 10, 2026
pulisher
Apr 08, 2026

Tech Rally: Is Cocrystal Pharma Inc stock risky to hold nowMarket Activity Summary & Consistent Profit Trading Strategies - baoquankhu1.vn

Apr 08, 2026
pulisher
Apr 07, 2026

COCP: Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Prevention - Zacks Small Cap Research

Apr 07, 2026
pulisher
Apr 07, 2026

Is Cocrystal (COCP) Stock Cheap at Current Price | Price at $1.47, Down 2.00%Support Bounce - Newser

Apr 07, 2026
pulisher
Apr 05, 2026

Cocrystal Pharma, Inc. (COCP) stock price, news, quote and history - Yahoo Finance UK

Apr 05, 2026
pulisher
Apr 04, 2026

COCP PE Ratio & Valuation, Is COCP Overvalued - Intellectia AI

Apr 04, 2026
pulisher
Apr 04, 2026

We're Keeping An Eye On Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Rate - Yahoo Finance

Apr 04, 2026
pulisher
Apr 03, 2026

Shares +48% after hours: COCP Cocrystal Pharma NASDAQ 03 Apr earnings spotlight - meyka.com

Apr 03, 2026
pulisher
Apr 03, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session - Sahm

Apr 03, 2026
pulisher
Apr 03, 2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm

Apr 03, 2026
pulisher
Apr 03, 2026

Crude Oil Rises Sharply; Acuity Shares Fall After Q2 Results - Sahm

Apr 03, 2026
pulisher
Apr 03, 2026

Nasdaq Down 1%; US Initial Jobless Claims Fall - Sahm

Apr 03, 2026
pulisher
Apr 03, 2026

Cocrystal Pharma Shares Soar After FDA Grants Fast Track Status To CDI-988 - Sahm

Apr 03, 2026
pulisher
Apr 03, 2026

COCP Stock Analysis: Cocrystal Pharma Inc. biotech stock surges 48 percent to 1.51 level - Xã Vĩnh Công

Apr 03, 2026
pulisher
Apr 02, 2026

FDA grants fast track status to Cocrystal’s norovirus drug By Investing.com - Investing.com Australia

Apr 02, 2026
pulisher
Apr 02, 2026

Cocrystal Pharma stock surges on FDA Fast Track designation By Investing.com - Investing.com Canada

Apr 02, 2026
pulisher
Apr 02, 2026

Cocrystal Pharma (COCP) Receives FDA Fast Track Status for Norov - GuruFocus

Apr 02, 2026
pulisher
Apr 02, 2026

Cocrystal Pharma stock surges on FDA Fast Track designation - Investing.com

Apr 02, 2026
pulisher
Apr 02, 2026

Cocrystal Pharma, Inc. (8CC.F) stock price, news, quote and history - Yahoo Finance UK

Apr 02, 2026
pulisher
Apr 02, 2026

Cocrystal Pharma Advances in Norovirus Study as Financial Challenges Loom - StocksToTrade

Apr 02, 2026
pulisher
Apr 02, 2026

Cocrystal Pharma Wins FDA Fast Track for Norovirus Drug - TipRanks

Apr 02, 2026
pulisher
Apr 02, 2026

COCP Stock Soars 75% — What Is The Link To Cocrystal’s Norovirus Treatment? - Stocktwits

Apr 02, 2026
pulisher
Apr 02, 2026

Cocrystal Pharma Advances Antiviral Trials Amid Financial Strategy Shift - timothysykes.com

Apr 02, 2026
pulisher
Apr 02, 2026

FDA grants fast track status to Cocrystal’s norovirus drug - Investing.com

Apr 02, 2026
pulisher
Apr 02, 2026

FDA Fast Track backs Cocrystal (Nasdaq: COCP) oral norovirus antiviral CDI-988 - Stock Titan

Apr 02, 2026

Cocrystal Pharma Inc (COCP) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Cocrystal Pharma Inc 주식 (COCP) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
FROST PHILLIP MD ET AL
Director
Feb 06 '26
Buy
0.95
50,000
47,280
1,888,551
FROST PHILLIP MD ET AL
Director
Dec 31 '25
Buy
0.95
50,000
47,275
1,838,551
FROST PHILLIP MD ET AL
Director
Dec 30 '25
Buy
0.97
20,000
19,310
1,788,551
FROST PHILLIP MD ET AL
Director
Dec 26 '25
Buy
0.97
40,000
38,944
1,768,551
FROST PHILLIP MD ET AL
Director
Dec 24 '25
Buy
0.97
25,000
24,258
1,728,551
FROST PHILLIP MD ET AL
Director
Nov 26 '25
Buy
0.99
4,000
3,975
1,703,551
FROST PHILLIP MD ET AL
Director
Nov 25 '25
Buy
0.94
20,000
18,812
1,699,551
$28.50
price up icon 0.78%
$50.76
price up icon 2.57%
$92.69
price down icon 3.01%
$138.73
price down icon 1.11%
$147.88
price down icon 0.02%
ONC ONC
$305.60
price up icon 2.86%
자본화:     |  볼륨(24시간):